PRESS RELEASE
Feb 13, 2024
ImmunoPrecise Antibodies (NASDAQ:IPA) Is Changing How We Look At The Complex World Of Antibody Discovery
Jan 10, 2024
ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms
Dec 07, 2023
ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14
Nov 22, 2023
ImmunoPrecise's BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery
Oct 20, 2023
Overcoming the Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological Data
Oct 13, 2023
How ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody Research
Aug 31, 2020
LD Micro -- 360 Companies Set to Present this Week
Aug 31, 2020
ImmunoPrecise to Present at The LD 500 Virtual Investor Conference
Mar 08, 2018
ImmunoPrecise to Present at the Inaugural LD Micro Virtual Conference
Dec 22, 2017
IIROC Trade Resumption - ImmunoPrecise Antibodies Ltd.